Paliperidone Palmitate versus Risperidone Long-Acting Injectable in Patients with Schizophrenia: A Meta-Analysis of Efficacy and Safety

Paliperidone Palmitate versus Risperidone Long-Acting Injectable in Patients with Schizophrenia: A Meta-Analysis of Efficacy and Safety

Mingjun Zhao,1,* Bin Qin,2,* Yage Mao,3 Yang Zhang,4 Ruisheng Zhao,5 Aiqin Wang,1 Hailing Wang,1 Jianting Zhao,6 Changhong Wang7 1Department of Pharmacy, The Second Affiliated Hospital of Xinxiang Medical University (Henan Mental Hospital), Xinxiang, People’s Republic of China; 2Depa...

Full description

Bibliographic Details
Main Authors: Zhao M, Qin B, Mao Y, Zhang Y, Zhao R, Wang A, Wang H, Zhao J, Wang C
Format: Article
Language:English
Published: Dove Medical Press 2023-04-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
paliperidone palmitate
risperidone
long-acting injectable
schizophrenia
meta-analysis
Online Access:https://www.dovepress.com/paliperidone-palmitate-versus-risperidone-long-acting-injectable-in-pa-peer-reviewed-fulltext-article-NDT

Internet

https://www.dovepress.com/paliperidone-palmitate-versus-risperidone-long-acting-injectable-in-pa-peer-reviewed-fulltext-article-NDT

Similar Items